| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/01/2006 | US7083946 Comprises nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cell proliferative, nervous system, autoimmune and cardiovascular disorders |
| 08/01/2006 | US7083944 Isolated nucleic acids; induction apoptosis |
| 08/01/2006 | US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083935 Androgen receptor complex-associated protein |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083930 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 08/01/2006 | US7083914 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds |
| 08/01/2006 | US7083820 Dehydration and stabilization of naturally occurring substance containing biologically active components, e.g. proteins, by heating with a microbiocide at a temperature below denaturization; food processing; drugs; cosmetics |
| 08/01/2006 | US7083803 Ocular solutions |
| 08/01/2006 | US7083798 Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositions |
| 08/01/2006 | US7083794 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
| 08/01/2006 | US7083793 Coding Mycobacterium tuberculosis; isolation protein |
| 08/01/2006 | US7083792 Immunologically active proteins from Borrelia burgdorferi |
| 08/01/2006 | US7083791 Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
| 08/01/2006 | US7083790 Extracellular serine protease |
| 08/01/2006 | US7083788 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 08/01/2006 | US7083786 Mannan binding lectin-associated serine protease-2; serine protease that acts in the MBLectin complement fixation pathway |
| 08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | US7083783 Administering adenosine 5"-diphosphate transferase proteins; reducing eye pressure |
| 08/01/2006 | US7083782 Method of treatment using interferon-tau |
| 08/01/2006 | US7083777 Induce activation lymphocytes, cytokines; response to antigens; isolated polypeptide with carrier |
| 08/01/2006 | CA2265485C Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 08/01/2006 | CA2165435C Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 08/01/2006 | CA2039315C Human hematopoietic stem cell |
| 07/31/2006 | CA2493282A1 Method and composition for inhibiting cancer cell growth using urease and weakly basic anti-cancer compounds |
| 07/27/2006 | WO2006079019A2 Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion |
| 07/27/2006 | WO2006078899A2 Mucin hypersecretion inhibitors based on the structure of mans and methods of use |
| 07/27/2006 | WO2006078870A2 Methods for treating adhesive capsulitis |
| 07/27/2006 | WO2006078816A2 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide |
| 07/27/2006 | WO2006078776A2 Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors |
| 07/27/2006 | WO2006078629A2 In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair |
| 07/27/2006 | WO2006078581A2 Inactivated pepsin fraction, pharmaceutical compositions, and methods for detecting and treating diseases |
| 07/27/2006 | WO2006078336A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 07/27/2006 | WO2006078320A2 Methods for manufacturing delivery devices and devices thereof |
| 07/27/2006 | WO2006078277A2 Dalbavancin compositions for treatment of bacterial infections |
| 07/27/2006 | WO2006078274A2 Beta-peptides |
| 07/27/2006 | WO2006078268A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 07/27/2006 | WO2006078223A1 Angiotensin i derivatives |
| 07/27/2006 | WO2006078211A1 Growth factor composition |
| 07/27/2006 | WO2006078067A1 Age production inhibitor, use of the same, and process for production of the same |
| 07/27/2006 | WO2006077824A1 Drugs for nerve cell regeneration |
| 07/27/2006 | WO2006077675A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | WO2006077456A1 Oral administration of therapeutic agent coupled to transporting agent |
| 07/27/2006 | WO2006077427A2 Antiviral drug combinations |
| 07/27/2006 | WO2006077424A1 Pharmaceutical compounds |
| 07/27/2006 | WO2006077309A1 Injectable pharmaceutical composition containing a catecholamine and a peptidic hormone |
| 07/27/2006 | WO2006077266A1 Use of soluble cd164 variants in inflammatory and/or autoimmune disorders |
| 07/27/2006 | WO2006077232A2 Multimeric soluble fas ligand for eliminating alloreactive t lymphocyte in allogenic harmatopoietic stem-cell transplantation transplantation |
| 07/27/2006 | WO2006077202A1 Novel nutraceutical compositions |
| 07/27/2006 | WO2006077152A2 Hla fusion molecules and uses thereof |
| 07/27/2006 | WO2006077035A1 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 07/27/2006 | WO2006058359A3 Protein allergen derivatives |
| 07/27/2006 | WO2006055806A9 Diagnostic, prognostic, and therapeutic factor smac/diablo in human cancer |
| 07/27/2006 | WO2006055260A3 Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
| 07/27/2006 | WO2006052860A3 Modulators of retinol-retinol binding protein (rbp)-transthyretin (ttr) complex formation |
| 07/27/2006 | WO2006050250A3 Dose forms comprising vx-950 and their dosage regimen |
| 07/27/2006 | WO2006050183A3 Inhibitors of sporeforming pathogens and applications of the same |
| 07/27/2006 | WO2006050041A3 Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis |
| 07/27/2006 | WO2006049681A3 Selective neuropeptide y2 receptor agonists |
| 07/27/2006 | WO2006047900A3 Novel topical application agents against mimic and age-related wrinkles |
| 07/27/2006 | WO2006047684A3 Tissue factor phospholipid vesicle particles and methods of use for coagulation |
| 07/27/2006 | WO2006047625A3 Method to promote wound healing |
| 07/27/2006 | WO2006044582A3 Use of baff to treat sepsis |
| 07/27/2006 | WO2006039592A9 Use of il-17- for maturation of oocytes |
| 07/27/2006 | WO2006037029A3 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 07/27/2006 | WO2006031363A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/27/2006 | WO2006028497A3 Active recombinant human lysozyme |
| 07/27/2006 | WO2006023976A3 Formulations and methods for modulating satiety |
| 07/27/2006 | WO2006015275A9 Method for enhancing bone formation |
| 07/27/2006 | WO2006014798A3 Methods and compositions for using sax2 |
| 07/27/2006 | WO2005123119A3 Administration of neutral endopeptidase to treat inflammatory bowel disease |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005113589A3 Modified antigen-presenting cells |
| 07/27/2006 | WO2005112980A3 Bi-lateral local renal delivery for treating congestive heart failure and for bnp therapy |
| 07/27/2006 | WO2005110459A3 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 07/27/2006 | WO2005110056A3 Compositions comprising addl receptor syngap |
| 07/27/2006 | WO2005110018A3 Therapies which act on neuropeptide s receptors |
| 07/27/2006 | WO2005082005A3 Positive modulator of bone morphogenic protein-2 |
| 07/27/2006 | WO2005070020A3 Gefitinib sensitivity-related gene expression and products and methods related thereto |
| 07/27/2006 | WO2005051871A9 Implantable sensors and implantable pumps and anti-scarring agents |
| 07/27/2006 | WO2005020902A3 Compositions and methods for treating and diagnosing irritable bowel syndrome |
| 07/27/2006 | WO2005002516A9 Leukocyte internalized peptide-drug conjugates |
| 07/27/2006 | WO2004094614A3 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 07/27/2006 | WO2004091517A3 Conjugates comprising human il-18 and substitution mutants thereof |
| 07/27/2006 | WO2004039948A3 Actriib fusion polypeptides and uses therefor |
| 07/27/2006 | WO2004024890A3 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 07/27/2006 | WO2004005883A3 Secreted and cytoplasmic tumor endothelial markers |
| 07/27/2006 | WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168670 identification of new gene families that are differentially expressed in cancerous human tissues compared to normal human tissues; useful as diagnostic agents or markers to detect cancer or to differentiate carcinoma from normal tissue in a sample; nucleotide sequence |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060168623 Method and system for providing a customized media list |
| 07/27/2006 | US20060167483 Method, instruments, and kit for autologous transplantation |
| 07/27/2006 | US20060167402 Method and composition for inhibiting cardiovascular cell proliferation |
| 07/27/2006 | US20060167271 Purified compounds that inhibit intracellular alphax4/paxillin binding |
| 07/27/2006 | US20060167229 Biologically active peptide conjugates |
| 07/27/2006 | US20060167228 Sequences from an endosymbiont and their uses |
| 07/27/2006 | US20060167223 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |